Shows / Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives is a podcast hosted by Drs. Diana Isaacs and Natalie Bellini aimed at providing a regular roundup of the latest clinically applicable insights across diabetes and metabolic diseases, with a focus on leveraging technology to improve care. A video version of each episode is available at HCPLive.com/Clinical/Endocrinology. Please direct podcast-related inquiries to PCampbell@MJHLifesciences.com. Editor's note: Episodes…
Episodes
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesCATALYST Trial, Mifepristone, and Hypercortisolism in T2D, with John Buse, MD, PhD
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, speak with…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesUpdates from Dexcom at ADA 2025, with Kevin Sayer
In this special episode recorded at 85th Scientific Sessions of the American Diabetes Association (ADA 2025), hosts Diana Isaacs, PharmD, an endocrine clinical…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesREDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD
In this special episode recorded at 85th Scientific Sessions of the American Diabetes Association (ADA 2025), hosts Diana Isaacs, PharmD, an endocrine clinical…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
ADA 2025 Preview
With a number of late-breaking presentations and high-profile phase 2 and 3 trials, the 2025 American Diabetes Association (ADA) Scientific Sessions reflect…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
American Diabetes Association Consensus Report on MASLD
In this episode of Diabetes Dialogue, cohostsDiana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
May 2025 Diabetes Tech & Breakthrough T1D Updates
In this episode of Diabetes Dialogue, co-hosts hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
INHALE-3 Trial and Afrezza, With Roy Beck, MD, PhD
In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: AACE 2025 Recap
Video Version Only on HCPLive!In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, co-hosts Diana Isaacs, PharmD, BCPS…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Real-World Impact of iLet Bionic Pancreas, With Steven Russell, MD, PhD
Video Version Only on HCPLive!In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Luna Automated Insulin Delivery, With Jon Brilliant and John Sjölund
Video Version Only on HCPLive!Key Episode Timestamps00:00:05 Introduction and Background of Luna Diabetes00:02:27 Overview of Luna and Its Unique…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Tirzepatide vs Semaglutide for Obesity, Understanding SURMOUNT-5
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!Full results from the SURMOUNT-5 trial show tirzepatide (Zepbound) led…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Dexcom G7, Libre App, and Medtronic Simplera Sync
Video Version Only on HCPLive! In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, an…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Semaglutide for MASH in ESSENCE Trial, With Arun Sanyal, MD
Video Version Only on HCPLive!In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, an…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: CATALYST Reveals High Prevalence of Hypercortisolism in T2D
Video Version Only on HCPLive!In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, an…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Oral GLP-1 Orforglipron in ACHIEVE-1 Trial
Video Version Only on HCPLive!In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesSCORE, Semaglutide, and ACC Wrap-up
In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Screening for Presymptomatic T1D with Rifka Schulman-Rosenbaum, MD
In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: SOUL and STRIDE Trials from ACC 2025
Video Version Only on HCPLive!In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Updates and News from ATTD 2025 Part 1
Video Version Only on HCPLive!In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Bionic Pancreas Brings AID to Primary Care & Telehealth
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: Understanding Control-IQ+ AID Algorithm with Laurel Messer, PhD, RN
Video Version Only on HCPLive!In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Impact of NovoCare Pharmacy, LillyDirect Self Pay on GLP-1 RA Access
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
1: News and Updates in Diabetes Care from February 2025
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Omnipod 5 and Medtronic 780G for Type 2 Diabetes
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Understanding Semaglutide (Ozempic) in CKD and T2D
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!The US Food and Drug Administration (FDA) approval of semaglutide 1.0…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesADA’s 2025 Standards of Care in Diabetes Therapeutics
Video Version Only on HCPLive!In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, an…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
ADA’s 2025 Standards of Care in Diabetes Technology
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!Video Version only on HCPLive!In this episode of Diabetes Dialogue…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
The Evolving Role of Registered Dietitian Nutritionists in Obesity
In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, are joined…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesLeveraging Smart Algorithms for Insulin Optimization with Eran Atlas
Video version only on HCPLive!In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Insights on INHALE-1 and CATALYST Trials
Video Version only on HCPLive! In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss
Video Version Only on HCPLive!In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor
Welcome to this special edition of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosted by Diana Isaacs, PharmD, an endocrine…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Celebrating 25 Years of CGM, with Irl Hirsch, MD
Video Version only on HCPLive!In celebration of the podcast surpassing 100 episodes, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
News and Updates in Diabetes at AHA 2024
In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Tirzepatide’s Long-Term Obesity Data
In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Latest Updates on Semaglutide
Launched on November 14, 2024 to celebrate World Diabetes Day, this episode tackles a flurry of recent news and updates related to semaglutide…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Diabetes Tech Updates in October 2024
This episode spotlights news in diabetes technology from the latter half of October 2024. In the episode, hosts breakdown updates from multiple companies…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
What to Know About the Eversense 365 CGM, with Brian Hansen
On September 17, 2024, Ascensia Diabetes Care and Senseonics announced the US Food and Drug Administration's (FDA) clearance of the Eversense 365 system for…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Lingo Availability & Embecta's Tubeless Patch Pump
In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Real-World Experience with Dexcom Stelo
In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Sotagliflozin for T1D and Other ADCES Highlights
This episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, our second related to the Association of Diabetes Care and Education…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
First 10 Prices Announced from CMS Price Negotiations
On August 15, 2024, the Biden-Harris Administration announced the price list for the first 10 drugs selected as part of the Medicare price negotiations between…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Navigating ADCES 2024
The Association of Diabetes Care and Education Specialists (ADCES) is an organization ahead of its time in the world of healthcare. Often, those in medicine…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesSUMMIT and FINEARTS-HF, with Muthiah Vaduganathan, MD, MPH
In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, welcome Muthiah Vaduganathan, MD, MPH, cardiologist and codirector of the Center for…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Simplera CGM and Medtronic's Partnership with Abbott
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesCATALYST Trial and Hypercortisolism in T2D, with John Buse, MD, PhD
Even with the second half of the trial yet to be completed, results of the CATALYST trial have initiated a potentially seismic shift in discussions around the…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
New Early-Stage T1D Monitoring Guidance, with Anastasia Albanese-O'Neill, PhD, APRN
Less than a month after rebranding from JDRF to Breakthrough T1D, the leading type 1 diabetes advocacy organization has now released new consensus guidance…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesINHALE-3 and Diabetes Tech Updates, with Grazia Aleppo, MD
At the 84th American Diabetes Association (ADA) Scientific Sessions, INHALE-3 was among the trials to take center stage.A phase 4 trial comparing the use of…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesBlue Circle Health, with Monica Gomberg, MD
Despite being a chronic autoimmune disease, the burden of type 1 diabetes is often overlooked in public health discussions. Not only are patients with type 1…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Advances in AID and CGM at ADA 2024, with Davida Kruger, NP
In this special edition episode from the 84th American Diabetes Association Scientific Sessions, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, are…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesADA Introduces Obesity Association, with Robert Gabbay, MD, PhD
On the opening day of the 84th American Diabetes Association Scientific Sessions, the ADA ushered in a new era for their organization with the announcement of…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesPatient Considerations for Inhaled Insulin, with Carol Levy, MD
In this special edition recorded at the 84th American Diabetes Association Scientific Sessions, Carol Levy, MD, director of the Mount Sinai Diabetes Center and…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
ADA 2024 Diabetes Technology Recap
This special edition episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives focuses on top highlights and updates in diabetes…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
June 2024 Updates in Diabetes Technology and T1D
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, provide a June…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
GLAM and CRISTAL, Updates in Pregnancy
In this episode, hosts provide their audience with an overview of a pair of new studies on the topic of diabetes in pregnancy: the GLAM and CRISTAL studies.
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease
To celebrate the FLOW trial and break down what it means for people with type 2 diabetes and CKD, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
2024 ACP Type 2 Diabetes Recommendations
The American College of Physicians has released new recommendations in favor of SGLT2i and GLP-1 RA and against the use of DPP-4i as second-line therapies to…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, tackle a pair of related topics: what the STEP HFpEF DM trial from ACC.24 means for the…
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesWhat to Know about Sequel Med Tech's twiist AID System, with Alan Lotvin, MD
The diabetes community welcomed an additional tool to the armamentarium with the US Food and Drug Administration’s clearance of the twiist automated insulin…
- Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Hot Topics and Updates from ATTD 2024
In the third and final recap episode from the 17th annual International Conference on Advanced Technologies & Treatments for Diabetes, hosts of Diabetes…